NCT00038896View on ClinicalTrials.gov

Study Evaluating Venlafaxine ER in Adults With Panic Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Panic Disorder
Interventions
DRUG

Venlafaxine ER

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00038896 - Study Evaluating Venlafaxine ER in Adults With Panic Disorder | Biotech Hunter | Biotech Hunter